2401 - 2425 of 8112 Results
Title
Year
-
RESTRICTEDTitle: Inclusionary Trials: A Review of Lessons Not LearnedJournal Name: Epidemiologic ReviewsPublisher: Oxford University Press (OUP)Vol: 44Issue #: 1Start Page: 78End Page: 86Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/epirev/mxac007Best OA location URL: https://academic.oup.com/epirev/advance-article-pdf/doi/10.1093/epirev/mxac007/45890462/mxac007.pdfCitation Count: 6
-
RESTRICTEDTitle: Integrating Multimorbidity into a Whole-Body Understanding of Disease Using Spatial GenomicsJournal Name: Results and Problems in Cell DifferentiationPublisher: Springer International PublishingVol:Issue #:Start Page: 157End Page: 187Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-3-031-06573-6_5Citation Count: 0
-
OPENTitle: Machine Learning-Based Prediction of Impulse Control Disorders in Parkinson’s Disease From Clinical and Genetic DataJournal Name: IEEE Open Journal of Engineering in Medicine and BiologyPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 3Issue #:Start Page: 96End Page: 107Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/ojemb.2022.3178295Best OA location URL: https://ieeexplore.ieee.org/ielx7/8782705/8937520/09783181.pdfCitation Count: 6
-
OPENTitle: Mapping of a N-terminal α-helix domain required for human PINK1 stabilization, Serine228 autophosphorylation and activation in cellsJournal Name: Open BiologyPublisher: The Royal SocietyVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1098/rsob.210264Best OA location URL: https://doi.org/10.1098/rsob.210264Citation Count: 27
- Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topography2022OPENTitle: Metabolic brain pattern in dementia with Lewy bodies: Relationship to Alzheimer’s disease topographyJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 35Issue #:Start Page: 103080End Page: 103080Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103080Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103080Citation Count: 14
-
OPENTitle: NigraNet: An automatic framework to assess nigral neuromelanin content in early Parkinson’s disease using convolutional neural networkJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 36Issue #:Start Page: 103250End Page: 103250Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2022.103250Best OA location URL: https://doi.org/10.1016/j.nicl.2022.103250Citation Count: 8
-
OPENTitle: Pharmacokinetic, pharmacodynamic, and transcriptomic analysis of chronic levetiracetam treatment in 5XFAD mice: A MODEL‐AD preclinical testing core studyJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/trc2.12329Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398229Citation Count: 13
- Poster Session2022OPENTitle: Poster SessionJournal Name: Rinsho ShinkeigakuPublisher: Societas Neurologica JaponicaVol: 62Issue #: SupplementStart Page: S247End Page: S393Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5692/clinicalneurol.62_supplement_s247Best OA location URL: https://www.jstage.jst.go.jp/article/clinicalneurol/62/Supplement/62_62_supplement_S247/_pdfCitation Count: 0
-
OPENTitle: POSTERS - 15th Conference Clinical Trials Alzheimer’s Disease, November 29- December 2, 2022, San Francisco, CA, USAJournal Name: The Journal of Prevention of Alzheimer's DiseasePublisher: Elsevier BVVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.14283/jpad.2022.97Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734609Citation Count: 4
-
RESTRICTEDTitle: Should “on-demand” treatments for Parkinson’s disease OFF episodes be used earlier?Journal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 7Issue #:Start Page: 100161End Page: 100161Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.prdoa.2022.100161Best OA location URL: https://doi.org/10.1016/j.prdoa.2022.100161Citation Count: 7
-
OPENTitle: Sorting (Nexin-13) out Novel Insights into Endolysosomal Cholesterol ExportJournal Name: ContactPublisher: SAGE PublicationsVol: 5Issue #:Start Page: 251525642211145End Page: 251525642211145Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/25152564221114513Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/25152564221114513Citation Count: 2
-
OPENTitle: Subcellular and regional localization of mRNA translation in midbrain dopamine neuronsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 110208End Page: 110208Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2021.110208Best OA location URL: http://www.cell.com/article/S2211124721017125/pdfCitation Count: 39
-
RESTRICTEDTitle: The many genomes of Parkinson's diseaseJournal Name: International Review of NeurobiologyPublisher: ElsevierVol:Issue #:Start Page: 59End Page: 80Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/bs.irn.2022.07.007Citation Count: 3
-
RESTRICTEDTitle: The neuropsychiatry of Parkinson's disease: advances and challengesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 89End Page: 102Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00330-6Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800169Citation Count: 151
-
RESTRICTEDTitle: Therapeutics in the Pipeline Targetingα-Synuclein for Parkinson's DiseaseJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 74Issue #: 1Start Page: 207End Page: 237Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1124/pharmrev.120.000133Best OA location URL: https://pharmrev.aspetjournals.org/content/pharmrev/74/1/207.full.pdfCitation Count: 39
-
RESTRICTEDTitle: Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disordersJournal Name: Pharmacology & TherapeuticsPublisher: Elsevier BVVol: 229Issue #:Start Page: 107937End Page: 107937Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pharmthera.2021.107937Citation Count: 34
-
OPENTitle: Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore®Journal Name: European RadiologyPublisher: Springer Science and Business Media LLCVol: 32Issue #: 5Start Page: 2949End Page: 2961Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00330-021-08385-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00330-021-08385-9.pdfCitation Count: 15
-
OPENTitle: Vascular risk profile and white matter hyperintensity volume among Mexican Americans and non‐Hispanic Whites: The HABLE studyJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/dad2.12263Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/dad2.12263Citation Count: 8
-
OPENTitle: Western diet associated with increased post-stroke depressive symptomsJournal Name: Journal of Nutritional SciencePublisher: Cambridge University Press (CUP)Vol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1017/jns.2022.38Citation Count: 6
-
-
OPENTitle: Impact of COVID-19 Pandemic on (Health) Care Situation of People with Parkinson’s Disease in Germany (Care4PD)Journal Name: Brain SciencesPublisher: MDPI AGVol: 12Issue #: 1Start Page: 62End Page: 62Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci12010062Best OA location URL: https://www.mdpi.com/2076-3425/12/1/62/pdf?version=1641260939Citation Count: 9
-
OPENTitle: Outcomes Impacting Quality of Life in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal GelJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 12Issue #: 3Start Page: 917End Page: 926Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3233/jpd-212979Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212979?id=journal-of-parkinsons-disease%2Fjpd212979Citation Count: 12
-
OPENTitle: Tumor-Associated Regulatory T Cell Expression of LAIR2 Is Prognostic in Lung AdenocarcinomaJournal Name: CancersPublisher: MDPI AGVol: 14Issue #: 1Start Page: 205End Page: 205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3390/cancers14010205Best OA location URL: https://www.mdpi.com/2072-6694/14/1/205/pdf?version=1641282234Citation Count: 10
-
OPENTitle: Rapid motor progression of Parkinson’s disease associates with clinical and genetic variantsJournal Name: Frontiers in Bioscience-LandmarkPublisher: IMR PressVol: 26Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.52586/5044Best OA location URL: https://www.imrpress.com/journal/FBL/26/12/10.52586/5044/pdfCitation Count: 9
-
RESTRICTEDTitle: Systematic Review on Parkinson’s Disease Medications, Emphasizing on Three Recently Approved Drugs to Control Parkinson’s SymptomsJournal Name: International Journal of Environmental Research and Public HealthPublisher: MDPI AGVol: 19Issue #: 1Start Page: 364End Page: 364Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijerph19010364Best OA location URL: https://www.mdpi.com/1660-4601/19/1/364/pdf?version=1641285359Citation Count: 27